Stock Market News 9 October 2025

Turn Therapeutics (TTRX) Skyrockets After Nasdaq Debut – Biotech Breakthrough or Hype?

Company Profile – Background & Leadership Turn Therapeutics, Inc. is a Westlake Village, CA-based biotech company founded in 2015 renaissancecapital.com. The company (formerly named Global Health Solutions, Inc.) officially rebranded to Turn Therapeutics in Sept 2025 ahead of its Nasdaq listing stockanalysis.com. Turn’s

9 October 2025

Intellia Therapeutics Stock Soars on Gene-Editing Breakthrough – Analysts Eye 70–100% Upside

Intellia Background and Pipeline Intellia was an early pioneer of in-vivo CRISPR therapy. Based in Cambridge, MA, it was among the first to administer CRISPR-Cas9 therapies directly into patients ts2.tech. In 2021 Intellia reported the first clinical proof that in-body

9 October 2025

Biotechnology · Gene Editing · Investment Analysis · NASDAQ:NTLA · Pharma News · Stock Market

United Airlines Stock Skyrockets on Travel Boom: Is $130 Next for UAL?

Stock Price & Recent Performance As of market close Oct 8, 2025, UAL traded around $98.09 reuters.com, a ~1.5% gain for the day. In early pre-market Oct 9, it had jumped ~6% to ~$104 stockanalysis.com. Over the past week, UAL

9 October 2025

Airlines · Financial News · Investing · NASDAQ:UAL · Stock Market · Travel Industry

Bluejay Diagnostics (BJDX) Stock Skyrockets on Sepsis Test Hopes – What Investors Need to Know

Company Overview: A Near-Patient Diagnostics Specialist Bluejay Diagnostics, Inc. is a small Massachusetts-based medical diagnostics company focused on rapid near-patient testing solutions for critical care settings stocktitan.net. The company’s mission is to improve emergency and intensive care outcomes by enabling

9 October 2025

Diagnostics · Healthcare News · Investing · Medical Technology · NASDAQ:BJDX · Stock Market

AI Drug Discovery Goldmine? Inside Recursion Pharma’s Wild Stock Surge and What’s Next

Latest News (Oct 7–Oct 9, 2025) Stock Performance & Technical Analysis After languishing through the summer, Recursion’s share price came to life in early October 2025. By Oct 8 the stock had rebounded to around $6.09 insidermonkey.com, putting it near

9 October 2025

Artificial Intelligence · Biotechnology · Drug Discovery · NASDAQ:RXRX · Pharma Industry · Stock Market

American Airlines (AAL) Stock Takes Off on Travel Demand – Will It Keep Climbing or Hit Turbulence?

Stock Price and Recent Performance American Airlines’ stock has been on a turbulent ride in 2025. After starting the year in the high teens, AAL has sunk into the low double-digits – recently closing around $11.81 marketbeat.com. The slide accelerated

9 October 2025

Airlines · Investment · Market Analysis · Stock Market · Travel Industry

Serve Robotics (SERV) Stock Soars on DoorDash Deal – The Next Big Bet in AI Delivery?

Latest News & Developments (October 2025) Serve Robotics grabbed headlines this week with a major new partnership announcement. On October 9, 2025, the company revealed a deal with DoorDash to deploy Serve’s sidewalk delivery robots for food orders on the

9 October 2025

Artificial Intelligence · Delivery Services · Investing · NASDAQ:SERV · Stock Market · Technology News

Powell’s Next Move Could Make or Break 2025’s Record Stock Rally

Record Highs Amid a Tech-Fueled Rally Wall Street’s momentum in 2025 is undeniable – and increasingly historic. Stocks have been on a tear, repeatedly smashing records. After seven consecutive daily gains to start October, the market took only a brief

9 October 2025

Economic Outlook · Federal Reserve · Financial News · Investments · NASDAQ:AMD · NASDAQ:NVDA · NASDAQ:ORCL · NASDAQ:PLTR · Stock Market

Wolfspeed WOLF Stock’s Wild Comeback: From Bankruptcy to Boom – Price, News & Expert Forecasts

Wolfspeed, Inc. (NYSE: WOLF) has seen a stunning reversal in fortune. As of October 9, 2025, the stock trades around $30.36 per share, giving the company a market capitalization of roughly $0.7–0.8 billion reuters.com companiesmarketcap.com. Just weeks ago, Wolfspeed emerged

9 October 2025

Company Analysis · Expert Opinions · Financial News · Investing · NYSE:WOLF · Stock Market

Ferrari Stock Skids as EV Ambitions Shift: Inside RACE’s High-Octane Gamble

Ferrari in the Headlines: New Strategic Plan & Stock Shock In early October 2025, Ferrari N.V. held a high-profile Capital Markets Day (investor day) in Maranello, unveiling its 2030 strategic plan and updated guidance. The event proved dramatic – Ferrari’s

9 October 2025

Automotive Industry · Electric Vehicles · Ferrari News · Investment Strategies · NYSE:RACE · Stock Market

PepsiCo (PEP) Stock: Q3 Earnings Surprise, “Ozempic Effect” Fears & Activist Investor Shake-Up – What’s Next?

Key Data & Metrics (as of October 9, 2025) Metric Value Stock Price (Oct 8, 2025) $138.84 (close) marketbeat.comDown ~6% in past month; ~–6% YTD finviz.com indexbox.io 52-Week Range Low $127.60 – High $177.48 markets.businessinsider.com Market Capitalization ~$193 Billion markets.businessinsider.com

9 October 2025

Corporate News · Earnings Reports · Financial Trends · Investment Analysis · NYSE:PEP · Stock Market

Tilray’s 300% Rally and Surprise Profit: Is the Cannabis Comeback Real?

Tilray’s Strong Quarter Signals a Turnaround Tilray Brands kicked off its fiscal 2026 with better-than-expected results, signaling that aggressive cost-cutting and diversification efforts are bearing fruit. The company’s Q1 FY2026 revenue hit $209.5 million, a 5% increase over last year’s

9 October 2025

Cannabis Industry · Company Earnings · Investment Analysis · Market Trends · NASDAQ:TLRY · Stock Market